Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIIB
DGX
Add up to 3 more stocks
BIIB
Biogen Inc.
-0.72%
$215.78-1.58Delayed quote: Sep 15, 2026, 11:30 AM EDT
Market Cap
$31.88B
52W Range
$135.39 - $225.80
DGX
Quest Diagnostics Incorporated
+3.82%
$246.97+9.08Delayed quote: Sep 15, 2026, 11:30 AM EDT
Market Cap
$27.26B
52W Range
$171.18 - $247.19
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 38.19 | 26.22 |
| Forward P/E | 17.38 | 22.07 |
| P/B Ratio | 1.69 | 3.63 |
| P/S Ratio | 3.21 | 2.36 |
| P/FCF Ratio | 11.82 | 22.34 |
| EV/EBITDA | N/A | 16.53 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 67.7% | 33.1% |
| Operating Margin | 12.8% | 14.1% |
| Net Margin | 8.4% | 9.2% |
| ROE | 4.4% | 14.1% |
| ROA | 2.6% | 6.3% |
| ROIC | 4.3% | 8.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.87 | 1.59 |
| Quick Ratio | 1.26 | 1.46 |
| Debt/Equity | 0.44 | 0.85 |
| Interest Coverage | 7.63 | 5.79 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 1.4% |
| Payout Ratio | N/A | 35.2% |
| Yrs of Dividend Growth | 0 | 14 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.